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In order to obtain adequate information for the treatment of methicillin resistant Staphy-
lococcus  aureus (MRSA) infections, it is crucial to identify trends in epidemiological and
antimicrobial  resistance patterns of local S. aureus strains. Community and hospital acquired
S.  aureus isolates (n = 202) were characterized using staphylococcal cassette chromosome
mec  (SCCmec) typing, pulse ﬁeld gel electrophoresis (PFGE) analysis, spa typing and mini-
mal inhibitory concentration (MIC) determination. The prevalence of the Panton-Valentine
leukocidine  (pvl) and several antibiotic resistance genes among the isolates were also
detected  by PCR. All of the S. aureus isolates were susceptible to vancomycin, daptomycin
and  linezolid. Three hospital isolates were resistant to teicoplanin while 14 showed inter-
mediate  resistance to teicoplanin. The resistance patterns of community-acquired MRSA
(CA-MRSA)  isolates to other antimicrobials were similar to those of hospital-acquired MRSA
(HA-MRSA)  isolates except for clindamycin and gentamicin. There was excellent correlation
between  phenotypes and genotypes in the determination of S. aureus resistance to eryth-
romycin,  gentamicin, and tetracycline. The SCCmec type II and SCCmec type IV were the
predominant  types detected in hospital and community isolates, respectively. The most
frequently  encountered spa types were t002 and t030 both in HA- and CA-MRSA isolates.
Pulsotype  A was the most predominant pulsotype identiﬁed among the isolates tested, fol-
lowed by pulsotype B. Seventy-two hospital isolates (19 HA-MRSA and 53 HA-MSSA) and
10  CA-MRSA were positive for the pvl gene. This study shows that the combination of sus-
ceptibility  testing and various molecular methods has provided useful information on the
antibiotic  resistance and molecular diversity of S. aureus in a speciﬁc region of China. Thehigh proportion of pvl po
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ntroduction
ethicillin resistant Staphylococcus aureus (MRSA) is one of
he  most prevalent nosocomial bacterial pathogens.1–5 caus-
ng  a wide variety of diseases such as skin and soft tissue
nfections, bloodstream infections, pneumonia, osteomyelitis
nd  endocarditis, as well as toxin-mediated syndromes like
oxic  shock and food poisoning.1,4 MRSA was  ﬁrst identiﬁed
n  England in 1961 after which it emerged worldwide.3 MRSA
s  now responsible for infections with signiﬁcant morbidity
nd  mortality and it has developed resistance to multiple
ntimicrobial agents complicating the clinical treatment of
nfections.4–8 Since the 1990s, MRSA colonization and infec-
ions  have been increasingly reported among the general
opulation/community and are referred to as community-
cquired MRSA (CA-MRSA) strains.2 CA-MRSA strains have
een  reported in numerous countries such as Australia, New
ealand,  the United Kingdom, Canada and the United States.5
n 2008, a study performed in a teaching hospital in Wen-
hou,  China described and compared the characteristics of
ospital  and community acquired S. aureus strains.9 Isolates of
A-MRSA  are distinct from those of hospital-acquired MRSA
HA-MRSA)  in many  characteristics which include susceptibil-
ty  to antimicrobial agents, the type of genetic staphylococcal
assette chromosome mec (SCCmec) elements, and exotoxin
ene  repertoire.10
Currently, MRSA has become a notorious etiologic agent
oth  in health care facilities and in the community in
hina,  and several studies have shown that this tendency
s  increasing.2 According to a study published in 2005,
he  mean incidence of MRSA across China was  over 50%
ith  the prevalence in Shanghai being over 80%.11 It is,
herefore, of paramount importance to understand the molec-
lar  epidemiology and to potentially predict the trends in
ntibiotic-resistance patterns of MRSA strains both in hospi-
als  and within the community.
It appears that under the selective pressure caused by
he  extensive use of antibiotics, MRSA clones which carry
esistance genes can better adapt to environmental change.6
hese resistant genes include the erm genes (ermA, ermB, ermC)
ncoding  erythromycin resistance, the tet genes (tetK, tetL,
etM,  tetO) encoding tetracycline resistance and the aac(6′)-
ph(2′′), aph(3′)-III and ant(4′)-I genes that encode gentamicin
esistance.12,13 Resistance determinants can be transposed
rom one strain to another, sometimes across the species
arrier  by conjugation, mobilization, phage-mediated trans-
uction,  and via as yet unknown mechanisms, resulting
n  the wide dissemination of antibiotic resistance among
irculating staphylococcal strains. Therefore, there is a con-
inuous  requirement to determine the effectiveness of these
ntibiotics  against S. aureus infections and the enactment of
ffective  drug policies in China.
The aim of the present study was  to investigate the local
pidemiological and antimicrobial resistance patterns of S.
ureus strains in Shenyang, which is considered necessary
o  establish empirical and speciﬁc therapy guidance for S.
ureus  treatment. We identiﬁed the antibiotic susceptibility
atterns and the molecular characteristics of isolates using
everal  methods, including SCCmec typing, pulsed-ﬁeld gel3;1 7(6):682–690  683
electrophoresis (PFGE) analysis, spa typing, assessment of
several  antibiotic resistance genes and minimum inhibitory
concentration (MIC) determination. Since MSSA isolates car-
rying  pvl have been reported in the hospital environment and
are  thought to evolve into MRSA strains through acquisition
of  a type of SCCmec element that harbors mecA gene,6,14 the
prevalence of Panton-Valentine leukocidine (pvl) gene9 among
the  isolates was  also assessed.
Materials  and  methods
S.  aureus  isolate  collection
The Shengjing hospital, a 2045-bed tertiary care center located
in  Shenyang, is one of three afﬁliated hospitals of the China
Medical  University. The hospital serves patients mostly com-
ing  from three large provinces located in the northeast of
China  and admits over 70,000 patients annually.
The hospital-acquired S. aureus isolates were  obtained from
individual  patients between January and October 2008 at the
Shengjing  Hospital of China Medical University in Shenyang
from  the following departments: internal medicine, nephrol-
ogy,  hematology, gastroenterology, endocrinology, intensive
care  unit, respiratory medicine, surgical department, surgery
intensive  care, neurosurgery, thoracic surgery, and pediatrics.
In  total, 180 hospital-acquired S. aureus were  obtained from
different  clinical specimens, which included sputum (n = 94),
pus  (n = 41), blood (n = 25), urine (n = 9), prostatic ﬂuid (n = 4),
catheter  tips (n = 3), drainage ﬂuids (n = 3), and ascites (n = 1).
The  deﬁnition of hospital-acquired S. aureus infection was
as  follows: (1) an S. aureus infection identiﬁed at least 48 h
after  admission to a hospital; (2) a history of hospitaliza-
tion, surgery, dialysis, or residence in a long-term care facility
within  one year of the positive culture date; (3) a permanent
indwelling catheter or percutaneous medical device (e.g. tra-
cheostomy  tube, gastrostomy tube or Foley catheter) present
at  the time of culture; or (4) a known positive culture for S.
aureus  prior to the study period.15 As a comparison, 2103 third-
year  students from China Medical University (located in the
same  region as Shengjing hospital) were screened for nasal
carriage  of S. aureus from whom 22 MRSA were  identiﬁed.
These MRSA strains were deemed to be of community origin
since  the students were all healthy and health care-related
risk factors were absent.2
Only one isolate from each patient or student was used.
Isolates were ﬁrst cultured on sheep blood agar (Becton
Dickinson, Cockeysville, MD) at 35 ◦C for 48 h. Phenotypic iden-
tiﬁcation  of S. aureus was  initially based on colony morphology
which  was  then conﬁrmed using the Pos Combo type 41
MicroScan panels (Baxter Diagnostics, Inc., West Sacramento,
CA).  All the isolates were stored in a storage solution (80%
glycerol,  20% brain heart infusion) at −80 ◦C.
Antimicrobial  susceptibility  test
MICs were determined using the broth microdilution method
according  to the procedure recommended by the Clini-
cal  and Laboratory Standards Institute.16,17 The antibiotics
tested were  penicillin G, oxacillin, tetracycline, erythro-
mycin, and gentamicin (Sigma Chemical Co., St. Louis,
i s . 2 0684  b r a z j i n f e c t d 
MO), cefoxitin (Fujisawa Pharmacy Co., Osaka, Japan), van-
comycin  (Sigma Chemical, St. Louis, MO), teicoplanin,
clindamycin, daptomycin, linezolid, rifampicin, levoﬂoxacin
(Daiichi Pharmaceutical Co., Tokyo, Japan), chlorampheni-
col and trimethoprim-sulfamethoxazole (SXT). The reference
strain  S. aureus ATCC 29213 was  used as a control standard in
each test.
DNA  extraction
Genomic DNA was  obtained from 2 mL  overnight cultures of
each  isolate using a Biospin Bacteria Genomic DNA Extrac-
tion  Kit (Biotechs Biological Technology Co., Ltd) and by
following  the manufacturer’s instructions. Five microlitres of
lysostaphin  (100 g/mL) were  added to digest the bacterial cell
wall  at 37 ◦C for 60 min.
PCR  detection  of  the  mecA  gene  and  SCCmec  typing
Methicillin resistant phenotypic identiﬁcation of the S. aureus
isolates  was  conﬁrmed by the detection of the mecA gene.
All  isolates were  subjected to mecA gene detection by PCR
using  primers mA1  and mA2  (Table 1). SCCmec typing was
performed using PCR according to previous reports.18,19 MRSA
strains  NCTC10442, N315, 85/2082, CA05 and WIS  were  used
as  reference standards for SCCmec typing (I, II, III, IV and V).
Detection  of  antimicrobial  resistance  genes  and  pvl  gene
Antibiotic resistance genes associated with macrolide resis-
tance  (ermA, ermB and ermC), aminoglycoside resistance
(aac(6′)-aph(2′′), aph(3′)-III, ant(4′)-I) and tetracycline resistance
(tetK,  tetL tetM, tetO) were  detected by PCR using previously
published protocols and primers as shown in Table 1.12,20,21
All S. aureus isolates were screened for the pvl toxin gene
by  PCR with primers pvl-1 and pvl-2 as described previously
(Table 1).6,22 MRSA strains MW2  was  used as a reference
standard for pvl gene identiﬁcation.
spa  typing
The spa gene encoding protein A of S. aureus was  used
for  MRSA typing and ampliﬁed by PCR with primers 1113F
and  1514R (Table 1).23 Sequencing of the spa gene was
performed by the Beijing Gene Institution (Beijing, China)
using  standard methods. The nucleotide sequences were ana-
lyzed using the RIDOM Staph-Type software (Ridom GmbH,
Germany)  to assign a spa type to the various isolates
(http://www.ridom.de/spaserver/).
PFGE  analysis
Chromosomal DNAs from the MRSA isolates were digested
with  SmaI and separated by PFGE using a Gene Path system
(CHEF-DR, PULS WAVE.760; Bio-Rad, Hercules, USA) according
to  the manufacturer’s instructions. A 48.5 kb ladder was  used
as  a DNA size marker (Bio-Rad, cat. # LS:170-3635). Isolates
were  considered identical when their PFGE patterns contained
the  same number and sizes of fragments. PFGE patterns with
fewer  than 4 band differences between an existing genotype 1 3;1  7(6):682–690
were  deﬁned as subtypes of that genotype.2,24 Genotypes were
categorized  alphabetically.
Statistical  analysis
Statistical comparisons were applied to determine the signiﬁ-
cance  of differences in resistance rates using Pearson’s 2 test
(SPSS  version 12.0). p-Values of less than 0.05 were  considered
statistically signiﬁcant.
Results
Antimicrobial  susceptibility
Of the 180 hospital-acquired S. aureus isolates identiﬁed, 107
were  MRSA and 73 were MSSA. Table 2 indicates that all
isolates  were  susceptible to vancomycin, daptomycin, and
linezolid.  Two HA-MRSA (1.9%) and one HA-MSSA (1.4%) iso-
lates  were resistant to teicoplanin and 13 HA-MRSA (12.1%)
isolates  and one HA-MSSA (1.4%) isolate showed intermediate
resistance to teicoplanin. There was  no signiﬁcant difference
in  the prevalence of teicoplanin resistance between HA-MRSA
and  HA-MSSA isolates (p > 0.05). All of the CA-MRSA isolates
were  susceptible to vancomycin, daptomycin, linezolid, and
teicoplanin.  In addition to the antibiotics above, the resis-
tant  rates to penicillin G, cefoxitin, erythromycin, levoﬂoxacin,
tetracycline, gentamicin, clindamycin were  higher for HA-
MRSA  isolates, at 98.1%, 98.1%, 97.2%, 96.2%, 93.4%, 91.6%,
and  87.9%, respectively. In contrast, the resistant rates to
rifampicin,  chloramphenicol, and SXT were moderately low, at
45.8%, 9.3%, and 10.3%, respectively. The resistance patterns
of  CA-MRSA isolates to the antibiotics tested were  similar to
those  of the HA-MRSA isolates for most of the antimicrobial
agents except for clindamycin and gentamicin.
Compared to HA-MRSA isolates, the HA-MSSA isolates pre-
sented  lower resistant rates to almost all antibiotics tested.
HA-MSSA  isolates showed resistance only to penicillin G,
erythromycin, clindamycin, tetracycline and gentamicin to
some degree. The predominant antibiotypes among the HA-
MRSA  isolates were  resistant to penicillin G, oxacillin, cefox-
itin,  erythromycin, tetracycline, gentamicin, levoﬂoxacin, and
clindamycin.  The predominant antibiotypes among the HA-
MSSA  isolates were those showing resistance to penicillin G,
erythromycin, and clindamycin.
Antimicrobial  resistance  genes
Table 3 shows that the ermA gene was frequently detected in
both  HA-MRSA (93/107, 86.9%) and HA-MSSA (59/73, 80.8%) iso-
lates while the detection rates of the ermB and ermC genes were
signiﬁcantly  higher in HA-MSSA isolates (51/73, 69.9%; 58/73,
79.5%)  compared to HA-MRSA isolates (49/107, 45.8%; 50/107,
46.7%).  The triple combination of ermA, ermB and ermC was
present  in 17.8% of HA-MRSA isolates and 49.3% of HA-MSSA
isolates. In contrast, the CA-MRSA isolates only possessed the
ermA  gene, which was  detected in 13 (59.1%) erythromycin-
resistant isolates.
In  this study, the HA-MRSA isolates were more  likely to con-
tain  the tetM (91.6% versus 69.9%), tetK (45.8% versus 19.2%)
b r a z j i n f e c t d i s . 2 0 1 3;1 7(6):682–690  685
Table 1 – Primers used in this study.
Gene name Primers Nucleotide sequence (5′–3′) Size of product (bp) Reference
mecA mA1  5′-TGCTATCCACCCTCAAACAGG-3′ 300 2
mA2  5′-AACGTTGTAACCACCCCAAGA-3′
pvl pvl-F  5′-ATGTCTGGACATGATCCAA-3′ 970 22
pvl-R  5′-AACTATCTCTGCCATATGGT-3′
ccr1-3 ccrB2Ino 5′-ATTGCCTTGATAATAGCCTTCT-3′ 700 19
CA1-4  5′-AACCTATATCATCAATCAGTACGT-3′
pSJ2223 C 5′-TAAAGGCATCAATGCACAAACACT-3′ 1000
LG12H3B 5′-AGCTCAAAAGCAAGCAATAGAAT-3′ 1600
ccrC SFCC4 5′-CCTTTATAGACTGGATTATTCAAAATAT-3′ 520 18
SFCC1  5′-CGTCTATTACAAGATGTTAAGGATAAT-3′
mecI-mecRI (class
A)
mI4  5′-CAAGTGAATTGAAACCGCCT-3′ 1900 2
mcR3  5′-GTCTCCACGTTAATTCCATT-3′
IS1272-mecA
(class B)
IS5  5′-AACGCCACTCATAACATATGGAA-3′ 2000
mA6 5′-TATACCAAACCCGACAAC-3′
IS431mecL- mecA
(class  C)
mA2  5′-AACGTTGTAACCACCCCAAGA-3′ 2000
IS2 5′-TGAGGTTATTCAGATATTTCGATGT-3′
ermA ermA-up  5′- TCTAAAAAGCATGTAAAAGAA-3′ 645 20
ermA-dn 5′- CTTCGATAGTTTATTAATATTAGT-3′
ermB ermB-up  5′- GAAAAGGATCTCAACCAAATA-3′ 639
ermB-dn 5′- AGTAACGGTACTTAAATTGTTTAC-3′
ermC ermC-up  5′- TCAAAACATAATATAGATAAA-3′ 642
ermC-dn 5′- GCTAATATTGTTTAAATCGTCAAT-3′
tetK tetK-up  5′- TATTTTGGCTTTGTATTCTTTCAT-3′ 1159 12
tetK-dn  5′- GCTATACCTGTTCCCTCTGATAA-3′
tetL tetL-up 5′- ATAAATTGTTTCGGGTCGGTAAT-3′ 1077
tetL-dn 5′- AACCAGCCAACTAATGACAATGAT-3′
tetO tetO-up  5′- AACTTAGGCATTCTGGCTCAC-3′ 1723
tetO-dn 5′- TCCCACTGTTCCATATCGTCA-3′
tetM tetM-up  5′- AGTTTTAGCTCATGTTGATG-3′ 1862
tetM-dn 5′-TCCGACTATTTGGACGACGG-3′
ant(4′)-I ant(4′)-I-a 5′-ATGGCTCTCTTGGTCGTCAG-3′ 367 21
ant(4′)-I-b 5′-TAAGCACACGTTCCTGGCTG-3′
aph-(3′)-III aph-(3′)-III-a 5′-CGATGTGGATTGCGAAAACT-3′ 175
aph-(3′)-III-b 5′-CACCGAAATAACTAGAACCC-3′
aac(6′)-aph(2′′) aac(6′)-aph(2′′)-a 5′-CATTATACAGAGCCTTGGGA-3′ 279
aac(6′)-aph(2′′)-b 5′-AGGTTCTCGTTATTCCCGTA-3′
spa 1113F  5′-TAAAGACGATCCTTCGGTGAGC-3′ Variable 23
1514R  5′-CAGCAGTAGTGCCGTTTGCTT-3′
Table 2 – Antibiotic resistance proﬁle of S. aureus (MSSA and MRSA) from Shenyang, China.
Antimicrobials Total no. of isolates (n = 202)
HA-MRSA (n = 107) CA-MRSA (n = 22) HA-MSSA (n = 73)
Resistant Intermediate Susceptible Resistant Intermediate Susceptible Resistant Intermediate Susceptible
PEN 105 (98.1) 0 (0.0) 2 (1.9) 22 (100.0) 0 (0.0) 0 (0.0) 67 (91.8) 0 (0.0) 6 (8.2)
OXA 107 (100.0) 0 (0.0) 0 (0.0) 22 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 73 (100.0)
FOX 105 (98.1) 0 (0.0) 2 (1.9) 22 (100.0) 0 (0.0) 0 (0.0) 1 (1.4) 0 (0.0) 72 (98.6)
VAN 0 (0.0) 0 (0.0) 107 (100.0) 0 (0.0) 0 (0.0) 22 (100.0) 0 (0.0) 0 (0.0) 73 (100.0)
TEC 2 (1.9) 13 (12.1) 92 (86.0) 0 (0.0) 0 (0.0) 22 (100.0) 1 (1.4) 1 (1.4) 71 (97.3)
CLI 94 (87.9) 1 (0.9) 12 (11.2) 6 (27.3) 0 (0.0) 16 (72.7) 38 (52.1) 0 (0.0) 35 (47.9)
RIF 49 (45.8) 1 (0.9) 57 (53.3) 7 (31.8) 0 (0.0) 15 (68.2) 1 (1.4) 0 (0.0) 72 (98.6)
GEN 98 (91.6) 2 (1.9) 7 (6.5) 3 (13.6) 0 (0.0) 19 (86.4) 19 (26.0) 0 (0.0) 54 (74.0)
LVX 103 (96.3) 0 (0.0) 4 (3.7) 18 (81.8) 0 (0.0) 4 (18.2) 6 (8.2) 1 (1.4) 66 (90.4)
CHL 10 (9.3) 0 (0.0) 97 (90.7) 0 (0.0) 0 (0.0) 22 (100.0) 2 (2.7) 1 (1.4) 70 (95.9)
ERY 104 (97.2) 0 (0.0) 3 (2.8) 20 (90.9) 0 (0.0) 2 (9.1) 56 (76.7) 1 (1.4) 16 (21.9)
SXT 11 (10.3) 0 (0.0) 96 (89.7) 2 (9.1) 0 (0.0) 20 (90.9) 2 (2.7) 2 (2.7) 69 (94.5)
LINE 0 (0.0) 0 (0.0) 107 (100.0) 0 (0.0) 0 (0.0) 22 (100.0) 0 (0.0) 0 (0.0) 73 (100.0)
DAPT 0 (0.0) 0 (0.0) 107 (100.0) 0 (0.0) 0 (0.0) 22 (100.0) 0 (0.0) 0 (0.0) 73 (100.0)
TCY 100 (93.5) 1 (0.9) 6 (5.6) 18 (81.8) 0 (0.0) 4 (18.2) 20 (27.4) 2 (2.7) 51 (69.9)
PEN, penicillin G; OXA, oxacillin; FOX, cefoxitin; VAN, vancomycin; TEC, teicoplanin; CLI, clindamycin; RIF, rifampicin; GEN, gentamicin;
LVX, levoﬂoxacin; CHL, chloramphenicol; ERY, erythromycin; SXT, trimethoprim-sulfamethoxazole; TCY, tetracycline; LINE, linezolid; DAPT;
daptomycin.
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Table 3 – Characterization of hospital isolates from Shenyang based on antibiotic susceptibility patterns and detection of antibiotic resistance genes.
Erythromycin Tetracycline Gentamicin No. of
isolates (%)
Pattern
(R or S)
Resistance genes No. of
isolates
(%)
Pattern
(R  or S)
Resistance genes No. of
isolates
(%)
Pattern
(R  or S)
Resistance genes
ermA ermB ermC tetM tetK tetL tetO aac(6′)-aph(2′′) aph(3′)-III ant(4′)-I
HA-MRSA
(n = 107)
R  + + − 30 (28.0) R + + − − 38 (35.5) R + − − 91 (85.0)
R + − + 25 (23.4) R + − − − 33 (30.8) R + + − 6 (5.6)
R + + + 19 (17.8) R + + − + 8 (7.5) R − − − 5 (4.7)
R + − − 19 (17.8) R + − − + 8 (7.5) S + − − 5 (4.7)
R − − + 3 (2.8) R + − + − 6 (5.6)
S − − − 8 (7.5) R − − − − 6 (5.6)
S − − + 3 (2.8) R + + + − 3 (2.8)
S − − − − 3 (2.8)
S + − − − 2 (1.9)
CA-MRSA
(n = 22)
R  + − − 13 (59.1) R + − − − 8 (36.4) R + − − 10 (45.5)
R − − − 8 (36.4) R − − − − 11 (50.0) R − − + 2 (9.1)
S − − − 1 (4.5) S − − − − 3 (13.6) R − − − 7 (31.8)
S − − − 3 (13.6)
HA-MSSA
(n = 73)
R  + + + 29 (39.7) R + + − − 7 (9.6) R + − − 15 (20.5)
R + − + 15 (20.5) S + − − − 22 (30.1) S − − − 44 (60.3)
R + + − 8 (11.0) S + − − + 15 (20.5) S + + − 7 (9.6)
S + + + 7 (9.6) S − − − − 15 (20.5) S + − − 7 (9.6)
S − + − 7 (9.6) S − + − − 7 (9.6)
S − − + 7 (9.6) S + − + + 7 (9.6)
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nd tetL (11.2% versus 9.6%) genes and less likely to contain
etO  (15.0% versus 30.1%) than the HA-MSSA isolates. Among
he  CA-MRSA isolates, 86.4% (19/22) were  resistant to tetracy-
line.  Only eight of these isolates possessed the tetM gene.
The  aminoglycoside-resistance gene aac(6′)-aph(2′′) was
dentiﬁed most frequently in HA-MRSA isolates (102/107,
5.3%). The aph(3′)-III gene was  detected in six (5.6%) HA-MRSA
nd  in seven (9.6%) HA-MSSA isolates but was not detected in
ny of the CA-MRSA isolates. Interestingly, the ant(4′)-I gene
as  detected in two CA-MRSA isolates (9.1%) but was  not
etected  in any of the hospital isolates.
olecular  characteristics  of  CA-MRSA  and  HA-S.  aureus
solates
CCmec types were  identiﬁed in 107 HA-MRSA and 22 CA-
RSA  isolates as shown in Table 4. Six HA-MRSA and one
A-MRSA  isolate(s) could not be assigned SCCmec types using
he  established protocols. For the HA-MRSA isolates, the most
requently  detected SCCmec types were SCCmec type II (43.0%,
6/107)  and SCCmec type III (28.0%, 30/107), followed by SCCmec
ype  V (13.1%, 14/107) and SCCmec type I (10.3%, 11/107). For
he  CA-MRSA, SCCmec type IV (68.2%; 15/22) and V (27.3%; 6/22)
ere  the most frequently found.
The spa types were  assigned by sequencing analysis of PCR
roducts  of the spa gene (Table 4). Nine spa types (t002, t030,
645,  t2793, t287, t2310, t2094, t571 and t2592) were  found in
80  of the hospital-acquired isolates and two (t002 and t030)
ere  found in 22 of the CA-MRSA isolates. The most frequently
ncountered spa types were shown to be t002 and t030 both in
A-MRSA (n = 57; n = 44) and CA-MRSA isolates (n = 19; n = 3).
A total of seven pulsotypes were  identiﬁed among the iso-
ates  and they were  classiﬁed into seven major groups (A to G)
ccording to their band patterns (data not shown). As shown in
able  4, the majority of the S. aureus isolates (n = 77), including
oth  hospital- and community-acquired isolates, belonged to
he pulsotype A cluster, followed by pulsotypes B, C and G.
revalence  of  the  pvl  gene
f 202 S. aureus isolates tested, 72 HA isolates (e.g., 19 HA-
RSA  and 53 HA-MSSA) and 10 CA-MRSA isolates were
ositive for the pvl gene. All of the 53 HA-MSSA isolates posi-
ive  for pvl were  obtained from pus while 19 of the pvl positive
A-MRSA isolates were obtained from 13 sputum and 6 ascite
amples.  Further statistical analysis showed that patients
ith  pvl positive HA-MRSA isolates were older than pvl pos-
tive  HA-MSSA carriers (65.8 year versus 11.9 year; p < 0.05).
wo  SCCmec types were  identiﬁed among the 19 pvl positive
A-MRSA isolates, namely the SCCmec type II (10/107; 9.3%)
nd  type V (3/107; 2.8%). Among the 22 CA-MRSA isolates, the
vl  positive isolates were  SCCmec type IV (6/22; 27.3%) and type
 (3/22; 13.6%).
iscussionhis study reveals that the HA-MRSA, HA-MSSA and CA-MRSA
solates  differ signiﬁcantly in antimicrobial susceptibility
Table 2). Considering the low resistance rates of HA-MRSA3;1 7(6):682–690  687
and  CA-MRSA to vancomycin, teicoplanin, chloramphenicol,
daptomycin, linezolid and SXT, these antimicrobials may  still
be effective in therapy for S. aureus infections. In contrast,
the  high resistance rates of isolates to penicillin, oxacillin,
cefoxitin, levoﬂoxacin, erythromycin, tetracycline, strongly
indicates  that the use of these antibiotics should not be
encouraged for treating patients with such S. aureus infections
in  the Shenyang region of China.
All S. aureus isolates were susceptible to vancomycin, dap-
tomycin  and linezolid. However two (1.9%) HA-MRSA and
one  (1.4%) HA-MSSA isolates were resistant to teicoplanin
while 13 (12.1%) HA-MRSA and one (1.4%) HA-MSSA isolate
showed  intermediate resistance to this antibiotic. Glycopep-
tides  including vancomycin and teicoplanin are of great
importance in the treatment of patients with penicillinase-
producing and methicillin-resistant S. epidermidis and S. aureus
infections.25 However, along with the increasing use of van-
comycin  and teicoplanin in clinical practice, there have been
numerous  reports on the emergence of MRSA with reduced
susceptibility to glycopeptides in addition to teicoplanin ther-
apy  failure.26–28 Since our study showed that teicoplanin
resistance was  present in HA-MRSA and HA-MSSA isolates,
it  would seem prudent to routinely screen both MRSA and
MSSA  isolates for reduced susceptibility to both vancomycin
and  teicoplanin. Our results also indicated that daptomycin
and  linezolid remain effective in treating those MRSA or MSSA
strains  exhibiting teicoplanin intermediate resistance.
As  shown in Table 2, about 97.2%, 93.5%, 91.6% and 87.9%
of  the HA-MRSA isolates were resistant to erythromycin,
tetracycline, gentamicin and clindamycin, respectively. In
addition,  13.6% and 27.3% of CA-MRSA isolates were  resistant
to  gentamicin and clindamycin. Compared to the HA-MRSA
isolates, the CA-MRSA isolates were  therefore more  likely to
be susceptible to gentamicin and clindamycin. Clindamycin is
recommended by current guidelines as an option for the man-
agement  of CA-MRSA infections.29 Nevertheless, resistance to
clindamycin was  detected in 27.3% of the CA-MRSA in this
study,  a fact that should be taken into consideration in the
future  management of CA-MRSA. Most of the HA-MSSA and
CA-MRSA  isolates manifested susceptibility to several antimi-
crobials  excluding the -lactams (e.g. penicillin G, oxacillin,
cefoxitin), and both CA-MRSA and HA-MSSA isolates showed
low  resistance to gentamicin. However, compared to CA-
MRSA,  HA-MSSA isolates were more  likely to have high-level
resistance to clindamycin. It may  be that the HA-MSSA iso-
lates  demonstrate reduced susceptibility to clindamycin due
to  the selective pressures in the clinical setting.
Table 3 demonstrates that ermA was  the most common
gene encoding macrolides resistance in both the hospital and
community  acquired S. aureus isolates. The ermB and ermC
genes  were  more  prevalent in HA-MSSA than in HA-MRSA
isolates. Other investigators have also found that ermA is the
dominant  erm gene in S. aureus.13 Table 3 shows that three
HA-MRSA and 21 HA-MSSA isolates were  susceptible to eryth-
romycin  even though they possessed at least one of the three
erm  genes. Similarly, Sekiguchi et al. 30 found discordance
among phenotypic erythromycin susceptibility and the pres-
ence  of erm genes. They stated that this discordance might
be  attributed to a mutation in the coding or promoter region
of  the genes. We  also noted that eight of CA-MRSA were
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Table 4 – Molecular characteristics of isolates from hospital and community settings and detection of virulence genes.
Isolates Pulsotype No. of isolates spa type Antibiotic resistance
proﬁlea
pvl toxin gene SCCmec type
I II III IV V NTb
HA-MRSA
n = 107
A  51 t002 POFYGLET − 8
POFYGLET − 27
POFYGLET + 10
POFGLET − 3
POFYGLET − 3
B 44 t030 POiE − 3
POFYRGLHEST − 3
POFYRGLET − 24
POFCYGLET − 3
POFRGLT − 3
POFYRGLET − 8
D 6 t002 POFYRGLET − 3
POFRGLT  + 3
E 3 t2793 POFYGLET + 3
F 3 t287 POFCiYLHES + 3
CA-MRSA
n = 22
A  19 t002 POFGES − 8
POFYLES  + 6
POFYGET  − 1
POFLTS  + 1
POFYGET + 2
POFL  − 1
B 3 t030 POFGLETS − 2
POFYGLETS  + 1
HA-MSSA
n = 73
C  29 t645 PYE + NEc
PYT − NE
P + NE
8 t2793 PYE + NE
7 t2310 PYE + NE
G 8 t287 PRSi − NE
7 t2094 P + NE
A 7 t571 PYGE − NE
B 7 t2592 PE + NE
a O, oxacillin; P, penicillin G; T, tetracycline; F, cefoxitin; S, trimethoprim-sulfamethoxazole; E, erythromycin; G, gentamicin; V, vancomycin; L,
levoﬂoxacin; R, rifampicin; C, Teicoplanin; Y, clindamycin; H, chloramphenicol; i, intermedial.b NT, nontypable.
c NE, not determined.
resistant to erythromycin but did not possess any erythromy-
cin  resistance genes as determined by PCR (Table 3). This might
be  explained by the location of these genes on small plas-
mids,  which were  occasionally lost.20,31,32 The most frequently
identiﬁed gene implicated in aminoglycoside resistance in
our  study was  aac(6′)-aph(2′′), which was  found in 95.3% of
HA-MRSA,  45.5% of CA-MRSA and 39.7% of HA-MSSA iso-
lates,  respectively. The Aph(3′)-III gene, infrequently found in
S. aureus, was  identiﬁed in 5.6% of HA-MRSA and 9.6% of
HA-MSSA  isolates, respectively. The ant(4′)-I gene, another
infrequently found gene in S. aureus, was  detected in 9.1% of
CA-MRSA  isolates.
The  use of several different molecular methods is cur-
rently  necessary for the accurate typing of MRSA, both in
outbreak  situations and for international comparisons.33 In
this  study, PFGE analysis indicated that the HA-MRSA isolates
could  be grouped into ﬁve different types (Pulsotype A, B, D, E
and F), pulsotype A was  the most predominant type (51/107;
47.7%),  followed by pulsotype B (44/107; 41.1%). Concurrently,
CA-MRSA isolates were grouped into two different types (Pul-
sotype  A and B), 19 belonged to pulsotype A and three strainsbelonged  to pulsotype B. The spa typing revealed four spa types
including  t002, t030, t2793 and t287 among the HA-MRSA iso-
lates,  while two spa types of t002 and t030 were  identiﬁed in
CA-MRSA.  The results demonstrated that the predominant spa
types (t002 and t030) and pulsotypes (A and B) in commu-
nity  acquired MRSA were also predominant among hospital
isolates,  which suggested that they shared the same clonal
origin.  This also indicates that the cross-transmission of S.
aureus  strains between the community and hospital environ-
ment  may  have occurred which is in accordance with previous
reports  documenting increasing colonization and infection
due  to MRSA strains of community origin in hospitals and vice
versa.34,35
SCCmec typing of HA-MRSA isolates revealed that 13.1%
(14/107)  strains carried SCCmec type V, which is mainly car-
ried  by CA-MRSA isolates36 indicating that HA-MRSA and
CA-MRSA isolates might not be distinguished merely by iden-
10tifying  their SCCmec genotypes. Ma  et al. reported that 49
of  51 strains (96.0%) isolated from both community- and
healthcare-associated cases in Uruguay carried either SCCmec
type  IV or SCCmec type V elements. In recent years, there
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ave been numerous reports describing nosocomial outbreaks
aused  by strains harboring SCCmec type IV, which was
riginally identiﬁed in CA-MRSA strains.37,38 Compared with
CCmec  type I, II and III, SCCmec type IV and type V are small
n  size and are more  prone to transfer between staphylococcal
pecies, presumably via phage-associated transduction.2,18,36
n this study, seven MRSA strains could not be assigned
CCmec  types using the established protocols. Presently work
s  being undertaken to assign SCCmec types to those seven
trains  using recently reported primers.45
Worldwide pandemic MRSA clones have been reported as
he  New York/Japan clone (ST5-type II SCCmec), the pediatric
lone  (ST5-type IV SCCmec), the archaic clone (ST250-type I
CCmec), the Iberian clone (ST247-SCCmec type 1A), and the
razilian/Hungarian clone (ST239-type III SCCmec) by Oliveira
t  al. 39 In the present study, we identiﬁed several different
RSA clones that were  distinguishable based on SCCmec typ-
ng, spa typing, and distinct antimicrobial resistance proﬁles
Table  4). We  conclude that spa types t030 and t002 were  the
wo  most common spa types identiﬁed in this study. Most
f  the t030 belong to the Brazilian ST239-MRSA-III epidemic
lones  while the t002 belong to both the New York/Japan
T5-MRSA-II and the pediatric ST5-MRSA-IV epidemic clones
hich  are the most prevalent in Asian countries, especially
hina.11,40
It is known that the pvl gene locus is carried on bacte-
iophages, namely PVL, SLT, Sa2mw and 108PVL, which
ncode pvl components. S. aureus isolates producing PVL
ave  been strongly associated with severe skin and soft-
issue  infections (SSTIs), and occasionally, severe necrotizing
neumonia.6 Some previous studies have described a low
revalence of pvl genes (<5%) in HA-MRSA,41,42 while pvl pos-
tive  CA-MRSA clones have spread globally.2,43 In our study,
he  pvl gene was  identiﬁed in 17.8% (19/107) of HA-MRSA and
5.5%  (10/22) CA-MRSA isolates, respectively. In Taiwan, dur-
ng  2005 the prevalence of pvl positive MRSA isolates was  23.3%
n  hospitals.44 Yu et al. also reported the prevalence of the pvl
ene  among clinical isolates of S. aureus in a teaching hospi-
al,  and most of the pvl positive isolates were SCCmec type III.9
urthermore, in this study we also found a high prevalence of
vl  positive MSSA isolates of hospital origin.
Overall, the present study suggests a bi-directional move-
ent  of S. aureus strains between healthcare and community
ettings in Shenyang, China. The spread of pvl positive MRSA
lones  with speciﬁc genotypes within hospitals and the com-
unity  is a particular cause of concern and could have
mportant implications for the implementation of effective
nfection control strategies and measures.
onclusions
his study has shown that the combination of susceptibility
esting and various molecular methods provides useful infor-
ation  on the antibiotic resistance and molecular diversity of
.  aureus in a region of Northeastern China. Although the num-
er  of S. aureus isolates available for our investigation together
ith  relevant epidemiological data was  limited, the high pro-
ortion  of pvl positive MRSA and MSSA isolates observed in
his  study indicates that adequate measures are needed in
13;1 7(6):682–690  689
order to curtail and control the spread and establishment of
such  MRSA and MSSA isolates in Chinese health care institu-
tions.
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